UCLA performed most heart and lung transplants in the United States in 2016

Amanda GriswoldUCLA heart and lung transplants teams. UCLA performed the highest combined number of heart and lung transplants among all U.S. medical centers in 2016, according to United Network for Organ Sharing data, a nonprofit that manages the nation ’s organ transplant system.UCLA ’s thoracic transplant program performed 170 transplants during the 12-month period: 103 adult lung transplants, 58 adult heart transplants and nine pediatric heart transplants, according to UNOS.“This accomplishment is a tribute to our dedicated surgeons, physicians, nurses and allied health care professionals who are open to new challenges,” said Dr. Abbas Ardehali, the program’s surgical director. “We take pride in the innovative nature of our program and look forward to setting n ew standards in the years to come.”The UCLA program ranks among the country ’s best in terms of patient survival rates and outcomes of the transplanted organ, according to the Scientific Registry of Transplant Recipients. UCLA began performing heart transplants in 1985 and lung transplants in 1988. Thetransplant program has become a world leader and has pioneered numerous advances in transplant research, surgical technique, organ procurement and patient care.  
Source: UCLA Newsroom: Health Sciences - Category: Universities & Medical Training Source Type: news

Related Links:

We read with great interest the review by Yanagawa et al, entitled Surgery for tumors of the heart,1 where the authors thoroughly review cardiac tumors classification, diagnosis sequence as well as the suggested method of treatment for the different kinds of tumors. The authors address sarcoma's as one of the rare malignant tumors and suggest a two-step surgical approach to sarcoma that involve the heart and lung.
Source: Seminars in Thoracic and Cardiovascular Surgery - Category: Cardiovascular & Thoracic Surgery Authors: Tags: ADULT – Letter to the Editor Source Type: research
Chronic lung allograft dysfunction or CLAD, encompasses a variety of phenotypes including both obstructive and restrictive phenotypes as detected by pulmonary function testing (PFTs), and has advanced the understanding of current clinical guidelines1-5. From the initial classification of chronic lung allograft rejection based primarily on pulmonary function testing, clinical guidelines now encompass CLAD phenotypes, presumed causes, characteristic imaging findings, and refinement of histopathological grades.
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Authors: Source Type: research
Fight Aging! provides a weekly digest of news and commentary for thousands of subscribers interested in the latest longevity science: progress towards the medical control of aging in order to prevent age-related frailty, suffering, and disease, as well as improvements in the present understanding of what works and what doesn't work when it comes to extending healthy life. Expect to see summaries of recent advances in medical research, news from the scientific community, advocacy and fundraising initiatives to help speed work on the repair and reversal of aging, links to online resources, and much more. This content is...
Source: Fight Aging! - Category: Research Authors: Tags: Newsletters Source Type: blogs
By ANISH KOKA MD  The message comes in over the office slack line at 1:05 pm. There are four patients in rooms, one new, 3 patients in the waiting room. Really, not an ideal time to deal with this particular message. “Kathy the home care nurse for Mrs. C called and said her weight yesterday was 185, today it is 194, she has +4 pitting edema, heart rate 120, BP 140/70 standing, 120/64 sitting” I know Mrs. C well. She has severe COPD from smoking for 45 of the last 55 years. Every breath looks like an effort because it is. The worst part of it all is that Mrs. C just returned home from the hospital just days...
Source: The Health Care Blog - Category: Consumer Health News Authors: Tags: Health Policy Hospitals Medicare Anish Koka hospital readmissions HRRP MedPAC Source Type: blogs
Left Ventricular Assist Device (LVAD) support is a well established therapy for treatment of adult patients with end-stage heart failure (ESHF),1 in whom several types of devices varying in location, pump size, mechanics, and design are ‘officially’ available in the market. On the contrary, children with ESHF refractory to conventional therapy have much fewer ‘official’ and well-accepted options which require a continuous hospitalization and hinder patients’ mobility.2-13
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Authors: Tags: Editorial Source Type: research
68 year old man from Bangalore, got a new life as he underwent heart and lungs transplant at Narayana Health City, Bangalore. The donor is a 24yr old male fr...
Source: The Economic Times - Category: Consumer Health News Source Type: news
The risk of infection following heart transplantation is highest within the first year and represents the leading cause of early mortality. In this cohort of patients enrolled in the Outcomes AlloMap Registry (OAR), we sought to describe infection episodes (IEp) resulting in hospitalization, in early (
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Authors: Tags: Original Clinical Science – JHLT Source Type: research
Pulmonary cuff dysfunction, either due to pulmonary vein obstruction, pulmonary vein stenosis, or pulmonary vein thrombosis is an uncommon, yet serious complication after lung transplantation. While there have been numerous reports of its occurrence, there is little consensus regarding the hemodynamic parameters associated with its presentation and diagnostic considerations. This systematic review summarizes the evidence surrounding pulmonary cuff dysfunction after lung transplantation surgery and empirically analyzes its implications.
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Authors: Tags: Original Clinical Science Source Type: research
Some literature exists potentially linking proliferation signal inhibitors (PSIs) to venous thromboembolism (VTE). We sought to determine the impact of PSI on development of VTE in heart transplant (HT) patients while controlling for other risk factors.
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Authors: Tags: Original Clinical Science Source Type: research
Vasoplegic syndrome (VS) is a type of vasodilatory shock defined by a constellation of a high cardiac output state, low systemic vascular resistance (SVR), low filling pressures, and low mean arterial pressure (MAP) despite high-dose vasoconstrictors. It is a well-known phenomenon following cardiopulmonary bypass (CPB), with a reported incidence of 8-10%,1 and is more common following left ventricular assist device (LVAD) placement (42%).2 VS is associated with significant morbidity and a mortality rate ranging from 16-27%.
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Authors: Tags: Research Correspondence Source Type: research
More News: Cardiology | Cardiovascular & Thoracic Surgery | Health Management | Heart | Heart Transplant | Lung Transplant | Nurses | Nursing | Pediatrics | Transplant Surgery | Transplants